LUPKYNIS Drug-use Results Survey

Recruiting now

Conditions studied: Lupus Nephritis

In brief

The purpose of this study is to survey the safety of LUPKYNIS in patients with lupus nephritis under actual use conditions. In addition, information on efficacy will be collected.

Key facts

Study ID

NCT07053891

Run by

Otsuka Pharmaceutical Co., Ltd.

People needed

400

Starts

2025-09-17

Expected to finish

2032-06-30

Last updated by the study team

2025-09-19

Who can join

Age: 15 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who are newly starting administration of LUPKYNIS for lupus nephritis

Where it is running

• Pharmacovigilance Department — Osaka, Osaka, Japan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.